Psych Central - Clinical Trials for Social anxiety disorder

Clinical Trials for Social anxiety disorder

Found 173 studies with search of:

social anxiety disorder

Hide studies that are not seeking new volunteers.

1	Completed	Quetiapine in Social Anxiety Disorder
		Condition:	Social Anxiety Disorder
		Intervention:	Drug: quetiapine

2	Completed	A Combination Therapy In Patients With Social Anxiety Disorder
		Condition:	Social Anxiety Disorder
		Intervention:	Drug: vestipitant/paroxetine

3	Completed	Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder
		Condition:	Social Phobia
		Intervention:	Drug: AV608

4	Completed	Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder
		Condition:	Social Anxiety Disorder
		Intervention:	Drug: Gabitril

5	Recruiting	D-Cycloserine Enhancement of Exposure in Social Phobia
		Condition:	Social Anxiety Disorder
		Interventions:	Behavioral: Cognitive Behavioral Group Therapy (CBGT); Drug: D-Cycloserine

6	Completed	A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
		Condition:	Social Anxiety Disorder
		Intervention:	Drug: paroxetine

7	Not yet recruiting	An Open Label, Double-Blind Discontinuation Study of Quetiapine XR in Social Anxiety Disorder
		Condition:	Social Anxiety Disorder
		Interventions:	Drug: Quetiapine XR; Drug: Placebo

8	Recruiting	Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder
		Condition:	Social Phobia
		Interventions:	Drug: Clonazepam; Drug: Venlafaxine; Drug: Sertraline; Drug: Placebo

9	Completed	Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder
		Condition:	Social Phobia
		Interventions:	Drug: LY686017; Drug: paroxetine; Drug: placebo

10	Not yet recruiting	An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia
		Condition:	Social Anxiety Disorder
		Intervention:	Drug: Omega 3 Joy enteric coated concentrated fish oil

11	Completed	St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)
		Conditions:	Anxiety Disorders; Mental Health
		Intervention:	Drug: Hypericum perforatum (St. John's wort)

12	Recruiting	Geodon in Social Anxiety Disorder
		Condition:	Social Anxiety Disorder
		Intervention:	Drug: sertraline and ziprasidone

13	Active, not recruiting	Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism
		Conditions:	Social Anxiety Disorder; Social Phobia; Alcohol Use Disorder; Alcohol Abuse; Alcohol Dependence
		Interventions:	Drug: Paroxetine; Drug: Placebo

14	Completed	Nefazodone in the Treatment of Social Phobia
		Condition:	Social Anxiety Disorder (SAD)
		Intervention:	Drug: Nefazodone

15	Recruiting	Effect of Behavior Therapy on Responses to Social Stimuli in People With Social Phobia
		Condition:	Social Phobia
		Intervention:	Behavioral: Individual Cognitive Behavioral Therapy

16	Completed	The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public Speaking Environment
		Condition:	Social Phobia
		Intervention:	Drug: quetiapine

17	Recruiting	A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder
		Condition:	Social Anxiety Disorder
		Interventions:	Drug: Placebo treatment during 8 weeks; Drug: Paroxetine treatment during 8 weeks

18	Completed	Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder
		Condition:	Social Anxiety Disorder
		Intervention:	Drug: Venlafaxine ER

19	Completed	Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder
		Conditions:	Attention Deficit Hyperactivity Disorder; Comorbid Social Anxiety Disorder
		Interventions:	Drug: Atomoxetine hydrochloride; Drug: placebo

20	Completed	Treatment Of Patients With Social Anxiety Disorder
		Condition:	Social Anxiety Disorder
		Interventions:	Drug: GW876008; Drug: paroxetine

21	Terminated	Efficacy of Quetiapine in Generalised Social Anxiety Disorder
		Condition:	Social Anxiety Disorder
		Intervention:	Drug: quetiapine

22	Terminated	fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder
		Condition:	Social Anxiety Disorder
		Intervention:	Drug: GW679769

23	Recruiting	Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder
		Condition:	Generalized Social Anxiety Disorder
		Interventions:	Drug: atomoxetine; Drug: placebo

24	Recruiting	Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders
		Conditions:	Phobia, Social; Panic Disorder; Agoraphobia; Obsessive-Compulsive Disorder; Anxiety Disorders; Major Depressive Disorder
		Intervention:	Drug: Sertraline

25	Recruiting	Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome
		Condition:	Anxiety Disorder
		Intervention:	Drug: duloxetine

26	Recruiting	Efficacy of Adding Topiramate to Current Treatment in Treatment-Resistant Generalized Social Phobia (GSP)
		Condition:	Social Phobia
		Intervention:	Drug: Topiramate

27	Recruiting	Effect of D-Cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia
		Condition:	Social Anxiety Disorder
		Interventions:	Drug: D-cycloserine; Behavioral: Cognitive behavioral therapy (CBT); Drug: Placebo

28	Recruiting	Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning
		Condition:	Anxiety Disorders
		Intervention:

29	Not yet recruiting	Flushing in Social Anxiety Disorder on Cipralex
		Condition:	Social Anxiety Disorder
		Intervention:	Drug: Escitalopram

30	Active, not recruiting	Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
		Condition:	Social Anxiety Disorder
		Interventions:	Drug: Paroxetine; Behavioral: Cognitive behavioral therapy (CBT)

31	Completed	Social Anxiety Disorder Study Of Paroxetine
		Condition:	Phobic Disorders
		Intervention:	Drug: Paroxetine hydrochloride hydrate

32	Recruiting	A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder
		Condition:	Social Anxiety Disorder
		Interventions:	Drug: GSK561679; Drug: GW876008; Drug: alprazolam

33	Completed	Residential Cognitive and Interpersonal Therapy for Social Phobia
		Condition:	Social Phobia
		Intervention:	Behavioral: Cognitive Therapy, Interpersonal Therapy

34	Active, not recruiting	Assessment and Treatment of Social Skills Deficits in Individuals With Social Phobia
		Condition:	Social Phobia
		Interventions:	Behavioral: Social Skills Training; Behavioral: Exposure Treatment; Behavioral: Placebo

35	Completed	Treatment of Social Phobia
		Conditions:	Phobic Disorders; Social Phobia; Public Speaking Anxiety
		Interventions:	Behavioral: Cognitive behavior therapy; Behavioral: Performance-based exposure therapy; Behavioral: Psychosocial intervention

36	Not yet recruiting	Treatment of Social Phobia and Panic Disorder in Adults
		Conditions:	Social Phobia; Panic Disorder
		Interventions:	Behavioral: individual cognitive-behavioural therapy; Behavioral: stepped care model

37	Recruiting	A Comparison Between Internet Therapy and Group Therapy for Social Phobia - A RCT Using Cognitive Behvioural Therapy
		Condition:	Social Phobia
		Interventions:	Behavioral: CBT via the Internet; Behavioral: CBT group therapy

38	Active, not recruiting	PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients
		Condition:	Social Anxiety Disorder
		Interventions:	Drug: vestipitant; Drug: paroxetine

39	Completed	Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)
		Condition:	Anxiety Disorders
		Intervention:	Drug: levetiracetam

40	Completed	Treatment of Childhood Social Phobia
		Condition:	Social Phobia
		Interventions:	Behavioral: Social Effectiveness Therapy for Children (SET-C); Drug: Fluoxetine; Drug: Pill Placebo

41	Active, not recruiting	Primary Care Intervention Strategy for Anxiety Disorders
		Conditions:	Post-Traumatic Stress Disorder; Generalized Anxiety Disorder; Panic Disorder; Social Anxiety Disorder
		Interventions:	Behavioral: Cognitive-behavioral therapy; Drug: Psychotropic medication optimization; Behavioral: Treatment as Usual

42	Completed	St. John's Wort Versus Placebo in Social Phobia
		Condition:	Phobic Disorders
		Intervention:	Drug: St. John’s Wort

43	Completed	Long-Term Study Of Paroxetine in Women and Men
		Condition:	Phobic Disorders
		Interventions:	Drug: BRL29060A; Drug: paroxetine hydrochloride hydrate

44	Recruiting	Social Phobia Intervention Study of Mannheim
		Condition:	Social Phobia
		Intervention:	Behavioral: Stepped Care Program Psychotherapy

45	Recruiting	Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia
		Condition:	Phobic Disorders
		Intervention:	Drug: D-Cycloserine

46	Recruiting	A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder
		Condition:	General Anxiety Disorder, Social Anxiety Disorder
		Intervention:	Drug: Namenda/Memantine

47	Completed	Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety
		Conditions:	Schizophrenia; Schizoaffective Disorder; Social Anxiety Disorder
		Intervention:	Drug: Aripiprazole

48	Completed	Can Thought Field Therapy (TFT) Be Helpful for Patients With an Anxiety Disorder?
		Conditions:	Agoraphobia; Social Phobia
		Intervention:	Behavioral: Thought Field Therapy (TFT)

49	Recruiting	Acamprosate in Alcoholics With Comorbid Anxiety or Depression
		Conditions:	Alcohol Dependence; Major Depression; Social Anxiety Disorder; Generalized Anxiety Disorder
		Intervention:	Drug: Acamprosate

50	Completed	Treatment for Anxiety in Children
		Conditions:	Obsessive-Compulsive Disorder; Anxiety Disorders; Generalized Anxiety Disorder; Social Phobia; Separation Anxiety
		Intervention:	Drug: Fluvoxamine

Studies Shown (1-50)

Next (51-100)

RSS Feed for studies received in the last 14 days

Download Options

Back